Priyanka Sharma

Also affiliated with Bennett University, University of Kansas Medical Center

Biochemistry, Genetics and Molecular BiologyMedicine

Pilot corpus only

This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.

Top 100%percentile

0Author DataRank

Indexed papers

1in pilot corpus

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Why this DataRank?

An author's DataRank is the sum of the DataRanks of all 1 indexed paper attributed to them. A prolific author with many moderate-impact papers can outrank one with a single high-impact paper.

Author scores recompute whenever paper DataRanks are refreshed, so this number lags the underlying paper scores by at most one batch run.

Read the full methodology →

Papers

Driven by 26 papers. Top paper: “Cisplatin with veliparib or placebo in metastatic triple-negative breast cancer and BRCA mutation-associated breast cancer (S1416): a randomised, double-blind, placebo-controlled, phase 2 trial”.

Cisplatin with veliparib or placebo in metastatic triple-negative breast cancer and BRCA mutation-associated breast cancer (S1416): a randomised, double-blind, placebo-controlled, phase 2 trial

The Lancet Oncology(2023)10.1016/s1470-2045(22)00739-2

N/A

2.0DataRank · unranked

102 citations

Priyanka Sharma, William E. Barlow, Julie R. Gralow, Shannon L. Puhalla, Carey K. Anders +16 more

Phase III Randomized, Placebo-Controlled Trial of Endocrine Therapy ± 1 Year of Everolimus in Patients With High-Risk, Hormone Receptor–Positive, Early-Stage Breast Cancer

Journal of Clinical Oncology(2024)10.1200/jco.23.02344

N/A

0.646DataRank · unranked

17 citations

Jieling Miao, Lajos Pusztai, Matthew P. Goetz, Priya Rastogi, Patricia A. Ganz +17 more

Thymidine kinase activity levels in serum can identify HR+ metastatic breast cancer patients with a low risk of early progression (SWOG S0226)

Biomarkers(2023)10.1080/1354750x.2023.2168063

N/A

0.587DataRank · unranked

12 citations

Adrian Nordmark, Amy Williams, Costanza Paoletti, William E. Barlow, Erin F. Cobain +11 more

Image analysis-based tumor infiltrating lymphocytes measurement predicts breast cancer pathologic complete response in SWOG S0800 neoadjuvant chemotherapy trial

npj Breast Cancer(2023)10.1038/s41523-023-00535-0

N/A

0.498DataRank · unranked

11 citations

Yalai Bai, Vasiliki Pelekanou, Zeina Nahleh, Saba Shafi, Sneha Burela +12 more

Evaluating Serum Thymidine Kinase 1 in Patients with Hormone Receptor–Positive Metastatic Breast Cancer Receiving First-line Endocrine Therapy in the SWOG S0226 Trial

Clinical Cancer Research(2021)10.1158/1078-0432.ccr-21-1562

N/A

0.457DataRank · unranked

20 citations

William E. Barlow, Erin F. Cobain, Mattias Bergqvist, Rita S. Mehta, Julie R. Gralow +9 more

Race and clinical outcomes in hormone receptor-positive, HER2-negative, node-positive breast cancer in the randomized RxPONDER trial

JNCI Journal of the National Cancer Institute(2024)10.1093/jnci/djae314

N/A

0.443DataRank · unranked

10 citations

William E. Barlow, Julie R. Gralow, Funda Meric‐Bernstam, Kathy S. Albain, Daniel F. Hayes +19 more

Improvements in the Sequencing and Assembly of Plant Genomes

10.1101/2021.01.22.427724

N/A

0.396DataRank · unranked

13 citations

Othman Al-Dossary, Bader Alsubaie, Ibrahim Al-Mssallem, Onkar Nath, Neena Mitter +7 more

Prospective longitudinal study of kinetics of humoral response to one, two, or three doses of SARS-CoV-2 vaccine in hematopoietic cell transplant recipients

Bone Marrow Transplantation(2022)10.1038/s41409-022-01653-2

N/A

0DataRank · unranked

8 citations

Cory Bivona, Ben Liu, Maggie Nelson, Grace Martin, Muhammad Umair Mushtaq +14 more

ctDNA and residual cancer burden are prognostic in triple-negative breast cancer patients with residual disease

npj Breast Cancer(2023)10.1038/s41523-023-00512-7

N/A

0DataRank · unranked

43 citations

Bruce F. Kimler, Rachel Yoder, Kelsey Schwensen, Joshua M. Staley, Qamar J. Khan +11 more

Novel Prognostic Staging System for Patients With De Novo Metastatic Breast Cancer

Journal of Clinical Oncology(2023)10.1200/jco.22.02222

N/A

0DataRank · unranked

42 citations

Samantha M. Thomas, Daniel F. Hayes, Mariana Chávez‐MacGregor, Kimberly H. Allison, Jennifer De Los Santos +8 more

Ovarian cancer pathology characteristics as predictors of variant pathogenicity in BRCA1 and BRCA2

British Journal of Cancer(2023)10.1038/s41416-023-02263-5

N/A

0DataRank · unranked

19 citations

Susan J. Ramus, Melissa C. Southey, Nicola S. Meagher, Andreas Hadjisavvas, Esther M. John +87 more

Evaluation of the 12-Gene Molecular Score and the 21-Gene Recurrence Score as Predictors of Response to Neo-adjuvant Chemotherapy in Estrogen Receptor-Positive, HER2-Negative Breast Cancer

Annals of Surgical Oncology(2020)10.1245/s10434-019-08039-7

N/A

0DataRank · unranked

26 citations

Susanne Wagner, Darl D. Flake, Mark E. Robson, Lee S. Schwartzberg, Priyanka Sharma +7 more

356P Prognostic value of the residual cancer burden after neoadjuvant chemotherapy for invasive lobular breast cancer: An international pooled cohort study

Annals of Oncology(2023)10.1016/j.annonc.2023.09.535

N/A

0DataRank · unranked

1 citations

Helena Earl, Christina Yau, David Cameron, Jean Abraham, Larry Hayward +15 more

Data from Evaluating Serum Thymidine Kinase 1 in Patients with Hormone Receptor–Positive Metastatic Breast Cancer Receiving First-line Endocrine Therapy in the SWOG S0226 Trial

(2023)10.1158/1078-0432.c.6530384.v1

N/A

0DataRank · unranked

0 citations

William E. Barlow, Erin F. Cobain, Mattias Bergqvist, Rita S. Mehta, Julie R. Gralow +9 more

Data from Evaluating Serum Thymidine Kinase 1 in Patients with Hormone Receptor–Positive Metastatic Breast Cancer Receiving First-line Endocrine Therapy in the SWOG S0226 Trial

(2023)10.1158/1078-0432.c.6530384

N/A

0DataRank · unranked

0 citations

William E. Barlow, Erin F. Cobain, Mattias Bergqvist, Rita S. Mehta, Julie R. Gralow +9 more

Comparing the prognostic and predictive utility of serum thymidine kinase 1 and CA 15-3 in patients with hormone receptor positive metastatic breast cancer starting first-line endocrine therapy in SWOG S0226.

Journal of Clinical Oncology(2023)10.1200/jco.2023.41.16_suppl.1076

N/A

0DataRank · unranked

0 citations

William E. Barlow, Costanza Paoletti, Mattias Bergqvist, Amy Williams, Hanna Ritzén +11 more

Analysis of the Radiosensitivity Index in Paired Preneoadjuvant and Postneoadjuvant Therapy Triple-Negative Breast Cancer

International Journal of Radiation Oncology*Biology*Physics(2025)10.1016/j.ijrobp.2025.09.038

N/A

0DataRank · unranked

1 citations

Roberto Salgado, Julia White, Bruce F. Kimler, Rachel Yoder, Joshua M. Staley +12 more

Stromal tumor infiltrating lymphocytes and TNBC-DX provide complementary prognostic information in triple-negative breast cancer

JNCI Journal of the National Cancer Institute(2025)10.1093/jnci/djaf162

N/A

0DataRank · unranked

1 citations

Miguel Martín, Guillermo Villacampa, Marı́a del Monte-Millán, Rachel Yoder, Harsh B. Pathak +23 more

Race and Clinical Outcomes in Hormone Receptor-Positive, HER2-Negative, Node-Positive Breast Cancer in the Randomized RxPONDER Trial

UNC Libraries(2025)10.17615/dgtt-ap31

N/A

0DataRank · unranked

0 citations

Julie R. Gralow, Edith Perez, Kevin Kalinsky, Gabriel N. Hortobágyi, Nancy U. Lin +19 more

Cell State and Cell Type: Deconvoluting Circulating Tumor Cell Populations in Liquid Biopsies by Multi-Omics

Cancers(2023)10.3390/cancers15153949

N/A

0DataRank · unranked

19 citations

Serena Zheng, Sonia Maryam Setayesh, Michael Morikado, Arushi Agrawal, Rafael Nevarez +17 more

Results of a phase II randomized trial of cisplatin +/- veliparib in metastatic triple-negative breast cancer (TNBC) and/or germline BRCA-associated breast cancer (SWOG S1416).

Journal of Clinical Oncology(2020)10.1200/jco.2020.38.15_suppl.1001

N/A

0DataRank · unranked

49 citations

Eve T. Rodler, William E. Barlow, Julie R. Gralow, Shannon Leigh Huggins-Puhalla, Carey K. Anders +15 more

Neoadjuvant endocrine therapy use in early stage breast cancer during the covid-19 pandemic

Breast Cancer Research and Treatment(2021)10.1007/s10549-021-06153-3

N/A

0DataRank · unranked

41 citations

Megan E. Gregory, J.G. Bazan, Maryam B. Lustberg, Shoshana M. Rosenberg, Victoria Blinder +6 more

Reconstructing tumor trajectories during therapy through integration of multiple measurement modalities

bioRxiv (Cold Spring Harbor Laboratory)(2021)10.1101/2021.01.14.426737

N/A

0DataRank · unranked

2 citations

Jinfeng Chen, Onalisa Winblad, Anne O’Dea, Priyanka Sharma, Meghna S. Trivedi +13 more

Convergent evolution of resistance pathways during early stage breast cancer treatment with combination cell cycle (CDK) and endocrine inhibitors

bioRxiv (Cold Spring Harbor Laboratory)(2021)10.1101/2021.01.19.427299

N/A

0DataRank · unranked

0 citations

Jinfeng Chen, Patrick A. Cosgrove, Anne O’Dea, Priyanka Sharma, X. Cynthia +13 more

Overall survival in the OlympiA phase III trial of adjuvant olaparib in patients with germline pathogenic variants in BRCA1/2 and high-risk, early breast cancer

Annals of Oncology(2022)10.1016/j.annonc.2022.09.159

N/A

0DataRank · unranked

450 citations

Judy E. Garber, Richard D. Gelber, Greg Yothers, Manuel Taboada, L. Ross +93 more

Impact of low versus negative estrogen/progesterone receptor status on clinico-pathologic characteristics and survival outcomes in HER2-negative breast cancer

npj Breast Cancer(2022)10.1038/s41523-022-00448-4

N/A

0DataRank · unranked

76 citations

Bruce F. Kimler, Joshua M. Staley, Kelsey Schwensen, Yen Y. Wang, Karissa Finke +16 more